These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37244011)

  • 1. Translatability barriers between preclinical and clinical trials of AAV gene therapy in inherited retinal diseases.
    Shamshad A; Kang C; Jenny LA; Persad-Paisley EM; Tsang SH
    Vision Res; 2023 Sep; 210():108258. PubMed ID: 37244011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
    Schön C; Biel M; Michalakis S
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV-mediated gene therapy for retinal disorders in large animal models.
    Stieger K; Lhériteau E; Moullier P; Rolling F
    ILAR J; 2009; 50(2):206-24. PubMed ID: 19293463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for inherited retinal diseases: progress and possibilities.
    Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.
    Colella P; Auricchio A
    Hum Gene Ther; 2012 Aug; 23(8):796-807. PubMed ID: 22734691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-Associated Viral Vectors as a Tool for Large Gene Delivery to the Retina.
    Trapani I
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30970639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel adeno-associated viral vectors for retinal gene therapy.
    Vandenberghe LH; Auricchio A
    Gene Ther; 2012 Feb; 19(2):162-8. PubMed ID: 21993172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo.
    Carvalho LS; Xiao R; Wassmer SJ; Langsdorf A; Zinn E; Pacouret S; Shah S; Comander JI; Kim LA; Lim L; Vandenberghe LH
    Hum Gene Ther; 2018 Jul; 29(7):771-784. PubMed ID: 29325457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy.
    Boye SL; Choudhury S; Crosson S; Di Pasquale G; Afione S; Mellen R; Makal V; Calabro KR; Fajardo D; Peterson J; Zhang H; Leahy MT; Jennings CK; Chiorini JA; Boyd RF; Boye SE
    Mol Ther; 2020 Jun; 28(6):1464-1478. PubMed ID: 32304666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus-vectored gene therapy for retinal disease.
    Dinculescu A; Glushakova L; Min SH; Hauswirth WW
    Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Pharmacology Perspective on Development of Adeno-Associated Virus Vector-Based Retina Gene Therapy.
    Ford JL; Karatza E; Mody H; Nagaraja Shastri P; Khajeh Pour S; Yang TY; Swanson M; Chao D; Devineni D
    Clin Pharmacol Ther; 2024 Jun; 115(6):1212-1232. PubMed ID: 38450707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in AAV vector development for gene therapy in the retina.
    Day TP; Byrne LC; Schaffer DV; Flannery JG
    Adv Exp Med Biol; 2014; 801():687-93. PubMed ID: 24664759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-mediated gene therapy in mouse models of recessive retinal degeneration.
    Pang JJ; Lei L; Dai X; Shi W; Liu X; Dinculescu A; McDowell JH
    Curr Mol Med; 2012 Mar; 12(3):316-30. PubMed ID: 22300136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Mitigation of Immunogenicity: A Key to Personalized Retinal Gene Therapy.
    Varin J; Morival C; Maillard N; Adjali O; Cronin T
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Versatility of AAV vectors for retinal gene transfer.
    Surace EM; Auricchio A
    Vision Res; 2008 Feb; 48(3):353-9. PubMed ID: 17923143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cells.
    Klimczak RR; Koerber JT; Dalkara D; Flannery JG; Schaffer DV
    PLoS One; 2009 Oct; 4(10):e7467. PubMed ID: 19826483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Retinal Explant Culture for Ex Vivo Validation of AAV Gene Therapy.
    Orlans HO; Edwards TL; De Silva SR; Patrício MI; MacLaren RE
    Methods Mol Biol; 2018; 1715():289-303. PubMed ID: 29188522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.
    Kotterman MA; Yin L; Strazzeri JM; Flannery JG; Merigan WH; Schaffer DV
    Gene Ther; 2015 Feb; 22(2):116-26. PubMed ID: 25503696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus mediated gene therapy for retinal degenerative diseases.
    Stieger K; Cronin T; Bennett J; Rolling F
    Methods Mol Biol; 2011; 807():179-218. PubMed ID: 22034031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.